Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what advice the NHS gives to women on the use of Tamoxifen for the menopause.

The National Institute for Health and Care Excellence (NICE) is the independent body responsible for providing guidance on the prevention and treatment of ill health and the promotion of good health and social care for the National Health Service. NICE has provided recommendations on the use of tamoxifen in pre and postmenopausal women in its clinical guideline on ‘Early and locally advanced breast cancer: diagnosis and treatment’ which is currently being updated. The guideline can be found at:

https://www.nice.org.uk/guidance/cg80/chapter/1-Guidance#endocrine-therapy

NICE is currently updating the guideline, including its recommendations on the use of tamoxifen, and published draft updated guidance for consultation on 24 January.